Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul P Dobesh

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Pharmacotherapy|August 20, 2004
Evidence for extended prophylaxis in the setting of orthopedic surgeryPaul P Dobesh
Pharmacotherapy|September 1, 2004
Unfractionated heparin dosing nomograms: road maps to where?Paul P Dobesh,
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 4, 2003
Novel concepts: emerging data and the role of extended prophylaxis following hip fracture surgeryPaul P Dobesh
Pharmacotherapy|December 31, 2004
Ximelagatran: pharmacology, pharmacokinetics, and pharmacodynamicsPaul P Dobesh
Pharmacotherapy|August 25, 2009
Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitorPaul P Dobesh
Pharmacotherapy|July 30, 2009
Economic burden of venous thromboembolism in hospitalized patientsPaul P Dobesh
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 7, 2006
Managing hypertension in patients with type 2 diabetes mellitusPaul P Dobesh
Journal of Managed Care Pharmacy : JMCP|April 13, 2013
Stable angina: current state of disease managementPaul P Dobesh
Journal of Pharmacy Practice|December 25, 2013
Economic implications of inadequate treatment of venous thromboembolism and potential solutionsPaul P Dobesh
Pharmacotherapy|September 1, 2004
Economics of unfractionated heparin: beyond acquisition costPaul P Dobesh,
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Pharmacotherapy|August 20, 2004
Evidence for extended prophylaxis in the setting of orthopedic surgeryPaul P Dobesh
Pharmacotherapy|September 1, 2004
Unfractionated heparin dosing nomograms: road maps to where?Paul P Dobesh,
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 4, 2003
Novel concepts: emerging data and the role of extended prophylaxis following hip fracture surgeryPaul P Dobesh
Pharmacotherapy|December 31, 2004
Ximelagatran: pharmacology, pharmacokinetics, and pharmacodynamicsPaul P Dobesh
Pharmacotherapy|August 25, 2009
Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitorPaul P Dobesh
Pharmacotherapy|July 30, 2009
Economic burden of venous thromboembolism in hospitalized patientsPaul P Dobesh
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 7, 2006
Managing hypertension in patients with type 2 diabetes mellitusPaul P Dobesh
Journal of Managed Care Pharmacy : JMCP|April 13, 2013
Stable angina: current state of disease managementPaul P Dobesh
Journal of Pharmacy Practice|December 25, 2013
Economic implications of inadequate treatment of venous thromboembolism and potential solutionsPaul P Dobesh
Pharmacotherapy|September 1, 2004
Economics of unfractionated heparin: beyond acquisition costPaul P Dobesh,
Pageof 9